These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26049555)

  • 21. Prehospital triage of patients suffering severe dyspnoea using N-terminal pro-brain natriuretic peptide, the PreBNP trial: a randomised controlled clinical trial.
    Bøtker MT; Jørgensen MT; Stengaard C; Seidenfaden SC; Tarpgaard M; Granfeldt A; Mortensen TØ; Grøfte T; Friesgaard KD; Mærkedahl R; Pedersen AB; Lundorff S; Hansen TM; Kirkegaard H; Christensen EF; Terkelsen CJ
    Eur Heart J Acute Cardiovasc Care; 2018 Jun; 7(4):302-310. PubMed ID: 28492084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke.
    Hajsadeghi S; Kashani Amin L; Bakhshandeh H; Rohani M; Azizian AR; Jafarian Kerman SR
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):554-60. PubMed ID: 23422348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of NT-proBNP assay in the management of canine patients with heart disease.
    Oyama MA; Singletary GE
    Vet Clin North Am Small Anim Pract; 2010 Jul; 40(4):545-58. PubMed ID: 20610010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides.
    Maisel AS; Duran JM; Wettersten N
    Heart Fail Clin; 2018 Jan; 14(1):13-25. PubMed ID: 29153197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of and Prognostic Significance of Cardiac Involvement at Presentation in Hereditary Transthyretin-Derived Amyloidosis and the Value of N-Terminal Pro-B-Type Natriuretic Peptide.
    Klaassen SHC; Tromp J; Nienhuis HLA; van der Meer P; van den Berg MP; Blokzijl H; van Veldhuisen DJ; Hazenberg BPC
    Am J Cardiol; 2018 Jan; 121(1):107-112. PubMed ID: 29153245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and Prognostic Value of Depressive Symptoms and N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Eisenmenger Syndrome.
    Moon JR; Kang DR; Song J; Huh J; Kang IS; Chang SA; Park SW; Lee HJ
    Psychosom Med; 2015 Sep; 77(7):816-22. PubMed ID: 26355727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-terminal probrain natriuretic peptide as a biomarker of cardioembolic stroke.
    Fonseca AC; Matias JS; Pinho e Melo T; Falcão F; Canhão P; Ferro JM
    Int J Stroke; 2011 Oct; 6(5):398-403. PubMed ID: 21645267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of plasma brain natriuretic peptide for postoperative cardiac complications--a systemic review and meta-analysis.
    Young YR; Sheu BF; Li WC; Hsieh TM; Hung CW; Chang SS; Lee CC
    J Crit Care; 2014 Aug; 29(4):696.e1-10. PubMed ID: 24793659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinician's experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting.
    Alehagen U; Janzon M
    Eur J Heart Fail; 2008 Mar; 10(3):260-6. PubMed ID: 18304871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of serum N-terminal B-type natriuretic peptide in asymptomatic structural heart disease in Taiwanese population: Comparisons with current ESC Guidelines.
    Hung TC; Wang KT; Yun CH; Kuo JY; Hou CJ; Liu CY; Wu TH; Bezerra HG; Cheng HY; Hung CL; Yeh HI
    Int J Cardiol; 2017 Mar; 231():195-200. PubMed ID: 28087179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery.
    Chong CP; Ryan JE; van Gaal WJ; Lam QT; Sinnappu RN; Burrell LM; Savige J; Lim WK
    Am J Cardiol; 2010 Sep; 106(6):865-72. PubMed ID: 20816130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [NT-proBNP in practice: from chemistry to medicine].
    Jourdain P; Lefèvre G; Oddoze C; Sapin V; Dievart F; Jondeau G; Meune C; Galinier M
    Ann Cardiol Angeiol (Paris); 2009 Jun; 58(3):165-79. PubMed ID: 19457468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction.
    Fried I; Bar-Oz B; Algur N; Fried E; Gavri S; Yatsiv I; Perles Z; Rein AJ; Zonis Z; Bass R; Nir A
    Pediatrics; 2006 Oct; 118(4):e1165-8. PubMed ID: 16966393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-terminal pro-B-type natriuretic peptide and echocardiographic abnormalities in severely obese patients: correlation with visceral fat.
    Malavazos AE; Morricone L; Marocchi A; Ermetici F; Ambrosi B; Corsi MM
    Clin Chem; 2006 Jun; 52(6):1211-3. PubMed ID: 16723693
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic polymorphism of the type A human natriuretic peptide receptor (NPR-A) gene contributes to the interindividual variability in the BNP system.
    Weber M; Burian M; Dragutinovic I; Moellmann H; Nef H; Elsaesser A; Mitrovic V; Hamm C; Geisslinger G
    Eur J Heart Fail; 2008 May; 10(5):482-9. PubMed ID: 18436476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma pro-brain natriuretic peptide and electrocardiographic changes in combination improve risk prediction in persons without known heart disease.
    Jørgensen PG; Jensen JS; Appleyard M; Jensen GB; Mogelvang R
    Int J Cardiol; 2015 Dec; 201():104-9. PubMed ID: 26292277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory and clinical aspects of B-type natriuretic peptides.
    Elin RJ; Winter WE
    Arch Pathol Lab Med; 2004 Jun; 128(6):697-9. PubMed ID: 15163225
    [No Abstract]   [Full Text] [Related]  

  • 38. N-terminal pro-B-type Natriuretic Peptides' Prognostic Utility Is Overestimated in Meta-analyses Using Study-specific Optimal Diagnostic Thresholds.
    Potgieter D; Simmers D; Ryan L; Biccard BM; Lurati-Buse GA; Cardinale DM; Chong CP; Cnotliwy M; Farzi SI; Jankovic RJ; Lim WK; Mahla E; Manikandan R; Oscarsson A; Phy MP; Rajagopalan S; Van Gaal WJ; Waliszek M; Rodseth RN
    Anesthesiology; 2015 Aug; 123(2):264-71. PubMed ID: 26200179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide.
    Mogelvang R; Goetze JP; Schnohr P; Lange P; Sogaard P; Rehfeld JF; Jensen JS
    J Am Coll Cardiol; 2007 Oct; 50(17):1694-701. PubMed ID: 17950153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
    Podlecka-Piętowska A; Kochanowski J; Zakrzewska-Pniewska B; Opolski G; Kwieciński H; Kamińska AM
    Neurol Neurochir Pol; 2014; 48(2):111-5. PubMed ID: 24821636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.